This study was designated to estimate protective role of ETA and ETB receptor antagonist against endothelin 1 (ET-1)-induced oxidative stress in lungs and determine whether these effects are mediated by nitric oxide (NO) synthase. Experiments were performed on Wistar rats divided into the following groups: I - saline (0.9 % NaCl); II - ET-1 (3 microg/kg b.w.), III - BQ123 (1 mg/kg b.w.) + ET-1 (3 microg/kg b.w.), IV - BQ788 (3 mg/kg b.w.) + ET-1 (3 microg/kg b.w.), V - N-nitro-L-arginine methyl ester (L-NAME) (5 mg/kg b.w.) + ET-1 (3 microg/kg b.w.). ETA and ETB receptor antagonists or L-NAME were administered 30 min before ET-1 injection. The levels of the following substances were measured in the lungs homogenates: thiobarbituric acid reactive substances (TBARS), hydrogen peroxide (H(2)O(2)), reduced glutathione (GSH) and tumor necrosis factor-alpha (TNF-alpha). The results showed that ET-1 significantly increased TBARS, H(2)O(2) (respectively: p<0.001, p<0.02) and TNF-alpha levels (p<0.02) and decreased the GSH level (p<0.01) vs. CONTROL GROUP: On the other hand, prior administration of ETA receptor blocker (BQ123) significantly attenuated TBARS (p<0.01), H(2)O(2) (p<0.02), TNF-alpha (p<0.02) and increased GSH (p<0.02) levels vs. ET-1. However, prior administration of ETB receptor blocker BQ788 did not cause significant changes in the: TBARS, H(2)O(2) and TNF-alpha (p>0.05) levels, but significantly increased the GSH level and GSH/GSSG ratio (p<0.05). Administration of L-NAME significantly attenuated TBARS (p<0.001), H(2)O(2) (p<0.05), TNF-alpha (p<0.01) and increased GSH (p<0.05) levels vs. ET-1. In conclusion, we demonstrated that ET-1 induced oxidative stress in the lungs is mediated by ETA receptors. ETA receptor blockage inhibited generation of free radicals and TNF-alpha and ameliorated antioxidant properties. Moreover, generation of reactive oxygen species is mediated by NOS in the lungs.

Experimental and Clinical Physiology Department of Cardiovascular Physiology Medical University of Lodz Poland

000      

00000naa a2200000 a 4500

001      

bmc17012772

003      

CZ-PrNML

005      

20170425105016.0

007      

ta

008      

170412s2016 xr d f 000 0|eng||

009      

AR

024    7_

$a 10.33549/physiolres.933263 $2 doi

035    __

$a (PubMed)27429120

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xr

100    1_

$a Kleniewska, P. $u Experimental and Clinical Physiology, Department of Cardiovascular Physiology, Medical University of Lodz, Poland

245    10

$a Influence of endothelin 1 receptor blockers and a nitric oxide synthase inhibitor on reactive oxygen species formation in rat lungs / $c P. Kleniewska, A. Gorąca

520    9_

$a This study was designated to estimate protective role of ETA and ETB receptor antagonist against endothelin 1 (ET-1)-induced oxidative stress in lungs and determine whether these effects are mediated by nitric oxide (NO) synthase. Experiments were performed on Wistar rats divided into the following groups: I - saline (0.9 % NaCl); II - ET-1 (3 microg/kg b.w.), III - BQ123 (1 mg/kg b.w.) + ET-1 (3 microg/kg b.w.), IV - BQ788 (3 mg/kg b.w.) + ET-1 (3 microg/kg b.w.), V - N-nitro-L-arginine methyl ester (L-NAME) (5 mg/kg b.w.) + ET-1 (3 microg/kg b.w.). ETA and ETB receptor antagonists or L-NAME were administered 30 min before ET-1 injection. The levels of the following substances were measured in the lungs homogenates: thiobarbituric acid reactive substances (TBARS), hydrogen peroxide (H(2)O(2)), reduced glutathione (GSH) and tumor necrosis factor-alpha (TNF-alpha). The results showed that ET-1 significantly increased TBARS, H(2)O(2) (respectively: p<0.001, p<0.02) and TNF-alpha levels (p<0.02) and decreased the GSH level (p<0.01) vs. CONTROL GROUP: On the other hand, prior administration of ETA receptor blocker (BQ123) significantly attenuated TBARS (p<0.01), H(2)O(2) (p<0.02), TNF-alpha (p<0.02) and increased GSH (p<0.02) levels vs. ET-1. However, prior administration of ETB receptor blocker BQ788 did not cause significant changes in the: TBARS, H(2)O(2) and TNF-alpha (p>0.05) levels, but significantly increased the GSH level and GSH/GSSG ratio (p<0.05). Administration of L-NAME significantly attenuated TBARS (p<0.001), H(2)O(2) (p<0.05), TNF-alpha (p<0.01) and increased GSH (p<0.05) levels vs. ET-1. In conclusion, we demonstrated that ET-1 induced oxidative stress in the lungs is mediated by ETA receptors. ETA receptor blockage inhibited generation of free radicals and TNF-alpha and ameliorated antioxidant properties. Moreover, generation of reactive oxygen species is mediated by NOS in the lungs.

650    _2

$a zvířata $7 D000818

650    _2

$a antagonisté endotelinového receptoru $x farmakologie $x terapeutické užití $7 D065128

650    _2

$a endotelin-1 $7 D019332

650    _2

$a glutathion $x metabolismus $7 D005978

650    _2

$a peroxid vodíku $x metabolismus $7 D006861

650    _2

$a peroxidace lipidů $x účinky léků $7 D015227

650    _2

$a plíce $x účinky léků $x metabolismus $7 D008168

650    _2

$a plicní nemoci $x etiologie $x metabolismus $x prevence a kontrola $7 D008171

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a NG-nitroargininmethylester $x farmakologie $x terapeutické užití $7 D019331

650    _2

$a synthasa oxidu dusnatého $x metabolismus $7 D019001

650    _2

$a oligopeptidy $x farmakologie $x terapeutické užití $7 D009842

650    _2

$a oxidační stres $x účinky léků $7 D018384

650    _2

$a cyklické peptidy $x farmakologie $x terapeutické užití $7 D010456

650    _2

$a piperidiny $x farmakologie $x terapeutické užití $7 D010880

650    _2

$a náhodné rozdělení $7 D011897

650    _2

$a potkani Wistar $7 D017208

650    _2

$a reaktivní formy kyslíku $x metabolismus $7 D017382

650    _2

$a receptor endotelinu A $x metabolismus $7 D044022

650    _2

$a receptor endotelinu B $x metabolismus $7 D044023

650    _2

$a TNF-alfa $x metabolismus $7 D014409

655    _2

$a časopisecké články $7 D016428

700    1_

$a Gorąca, A. $u Experimental and Clinical Physiology, Department of Cardiovascular Physiology, Medical University of Lodz, Poland

773    0_

$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 65, č. 5 (2016), s. 789-798

856    41

$u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu

910    __

$a ABA008 $b A 4120 $c 266 $y 4 $z 0

990    __

$a 20170412 $b ABA008

991    __

$a 20170421135234 $b ABA008

999    __

$a ok $b bmc $g 1201950 $s 973545

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2016 $b 65 $c 5 $d 789-798 $e 20160715 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824

LZP    __

$b NLK118 $a Pubmed-20170412